Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer
European Journal of Cancer2015Vol. 51(18), pp. 2777–2784
Citations Over TimeTop 1% of 2015 papers
Clare Schilling, Sandro J. Stoeckli, Stephan K. Haerle, Martina A. Broglie, Gerhard Huber, Jens Ahm Sørensen, Vivi Bakholdt, Annelise Krogdahl, Christian von Buchwald, Anders Bilde, Lars Sebbesen, Edward Odell, Benjamin Gurney, Michael O’Doherty, Remco de Bree, Elisabeth Bloemena, Géke B. Flach, Pedro M. Villarreal, Manuel Florentino Fresno Forcelledo, Luís Junquera, Julio Álvarez Amezaga, Luis Barbier Herrero, Joseba Santamaría-Zuazua, Augusto Moreira, Manuel Jácome, M G Vigili, Siavash Rahimi, Girolamo Tartaglione, Georges Lawson, Marie‐Cécile Nollevaux, Cesare Grandi, Davide Donner, Emma Bragantini, Didier Dequanter, Philippe Lothaire, Tito Poli, Enrico Maria Silini, E. Sesenna, Gilles Dolivet, Romina Mastronicola, Agnès Leroux, Isabel Sassoon, Philip Sloan, Mark McGurk
Related Papers
- → Value of sentinel node status as a prognostic factor in melanoma: prospective observational study(2006)61 cited
- → Clinicopathologic and Technical Factors Associated with the Uptake of Radiocolloid by Sentinel Nodes in Patients with Breast Cancer(2003)12 cited
- → Reply to “Current controversies on sentinel node biopsy in thin and thick cutaneous melanoma”(2016)1 cited
- → 758 Clinical consequences of node negative being positive in breast cancer(2003)
- → Response to the letter, “Underpowered conclusions can be potentially misleading with regards to the number of lymphoscintigraphy identified and surgically excised sentinel nodes in melanoma patients” by Nicholas C. Lee and Andrew J. Spillane(2011)